BlackRock Health Sciences Trust (BME) reappoints Park Charles as compliance chief

Rhea-AI Filing Summary

BlackRock Health Sciences Trust identified Park Charles as an officer and Chief Compliance Officer. The remarks state he previously served in this role from June 6, 2014 to June 30, 2023 and was reappointed effective August 1, 2026. No equity holdings or transactions are reported.

Key Figures

Prior CCO service start: June 6, 2014 Prior CCO service end: June 30, 2023 Reappointment effective date: August 1, 2026 +1 more

4 metrics

Prior CCO service start June 6, 2014 Date Park Charles began prior term as Chief Compliance Officer

Prior CCO service end June 30, 2023 Date Park Charles ended prior term as Chief Compliance Officer

Reappointment effective date August 1, 2026 Effective date of Park Charles’s reappointment as Chief Compliance Officer

Reported transactions 0 Number of equity transactions reported for Park Charles in this Form 3

Key Terms

Chief Compliance Officer, Reporting Person, issuer

3 terms

Chief Compliance Officer regulatory

"The Reporting Person was reappointed as Chief Compliance Officer of the Issuer"

The chief compliance officer is the senior executive responsible for making sure a company follows laws, industry rules and its own internal policies, acting like a safety inspector for legal and ethical risks. Investors care because effective compliance reduces the chance of fines, lawsuits, operational disruption and reputational damage, so the officer’s competence and independence can materially affect future profits and risk exposure.

Reporting Person regulatory

"The Reporting Person previously served as Chief Compliance Officer of the Issuer"

issuer regulatory

"Chief Compliance Officer of the Issuer from June 6, 2014 to June 30, 2023"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

Available on EDGAR 08/05/2026 - 06:28 PM Accepted by SEC EDGAR 08/05/2026 - 06:27 PM Learn about SEC filing dates

FAQ

What does the Form 3 filing for BME disclose about Park Charles?

The filing identifies Park Charles as an officer and Chief Compliance Officer of BlackRock Health Sciences Trust. It notes his prior service in this role and his reappointment effective August 1, 2026, with no equity holdings or transactions reported.

What role does Park Charles hold at BlackRock Health Sciences Trust (BME)?

Park Charles is reported as Chief Compliance Officer of BlackRock Health Sciences Trust. The remarks explain he previously served in this position and has been reappointed effective August 1, 2026, confirming his officer status with the issuer.

Are any insider share transactions reported in BME’s Form 3 for Park Charles?

No. The Form 3 for Park Charles reports no equity transactions. The transactions section is empty and the summary shows zero buy, sell, acquire, dispose, or derivative transactions, as well as zero holding entries associated with this reporting person.

What service history for Park Charles is disclosed for BME?

The remarks state that Park Charles served as Chief Compliance Officer from June 6, 2014 to June 30, 2023. They also state he was reappointed to the same role effective August 1, 2026, indicating a gap between his prior term and reappointment.

Does the BME Form 3 show current share ownership for Park Charles?

The Form 3 shows no reported holdings for Park Charles. The filing lists zero holding entries and includes no non-derivative or derivative ownership tables, so it does not present any specific share position for him.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Park Charles

(Last) (First) (Middle)

50 HUDSON YARDS

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2026

3. Issuer Name and Ticker or Trading Symbol
BlackRock Health Sciences Trust [ BME ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Compliance Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

The Reporting Person previously served as Chief Compliance Officer of the Issuer from June 6, 2014 to June 30, 2023. The Reporting Person was reappointed as Chief Compliance Officer of the Issuer effective August 1, 2026.

No securities are beneficially owned.

	/s/ Gladys Chang as Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)